원철희 ((주)레모넥스)님 | 한빛사연구자 > 한빛사

(주)레모넥스

최종업데이트 2021.11.23.

Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy
- Biomaterials, Available online 19 November 2021, 121257 | https://doi.org/10.1016/j.biomaterials.2021.121257
- 2021-11
- 의약학
- 한빛사논문
Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor
- Sci. Adv., 29 May 2020: Vol. 6, no. 22, eaaz8201 | DOI: 10.1126/sciadv.aaz8201
- 2020-05
- 바이오·의료융합
- 한빛사논문
Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
- Hepatology, Accepted manuscript online: 6 JUL 2015, 62:1160-1173 | DOI: 10.1002/hep.27968
- 2015-07
- 의약학
- 한빛사논문

연구자 ID

저자논문